Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,662	12,946	11,482	8,080	8,955	9,899
Market Cap Growth	40.38%	12.74%	42.11%	-9.78%	-9.54%	52.87%
Enterprise Value	13,963	12,342	10,756	7,809	8,566	9,721
PE Ratio	40.50	51.85	74.32	90.18	21.99	267.54
PS Ratio	7.40	6.86	7.71	7.13	8.56	12.56
PB Ratio	6.14	5.80	6.72	5.88	7.95	15.54
P/FCF Ratio	23.86	35.80	35.56	34.66	41.15	74.82
P/OCF Ratio	22.72	33.20	33.83	31.50	39.19	67.34
EV/Sales Ratio	7.04	6.54	7.23	6.89	8.19	12.33
EV/EBITDA Ratio	28.09	34.48	45.46	56.55	57.84	113.17
EV/EBIT Ratio	29.43	36.66	48.67	61.39	61.41	123.83
EV/FCF Ratio	22.73	34.13	33.31	33.50	39.37	73.48
Debt / Equity Ratio	0.21	0.19	0.15	0.32	0.37	0.78
Debt / EBITDA Ratio	1.03	1.20	1.11	3.19	2.78	5.77
Debt / FCF Ratio	0.83	1.18	0.81	1.89	1.89	3.75
Quick Ratio	2.33	2.25	2.49	3.65	5.14	1.42
Current Ratio	2.52	2.45	2.70	3.96	5.45	1.47
Asset Turnover	0.65	0.68	0.69	0.57	0.68	0.70
Interest Coverage	103.15	73.20	31.13	4.93	4.25	2.45
Return on Equity (ROE)	17.50%	12.90%	10.20%	6.90%	47.10%	7.00%
Return on Assets (ROA)	12.10%	9.00%	7.10%	4.50%	26.60%	3.30%
Return on Capital (ROIC)	12.61%	7.09%	9.13%	4.99%	40.44%	5.08%
Earnings Yield	2.52%	1.93%	1.35%	1.11%	4.55%	0.37%
FCF Yield	4.19%	2.79%	2.81%	2.88%	2.43%	1.34%
Buyback Yield / Dilution	-6.69%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%
Total Shareholder Return	-6.69%	-2.12%	-1.02%	-0.10%	-2.19%	-0.31%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).